Background: We hypothesize that urine levels might be reliable to assess the therapeutic range of caffeine.
Objectives: We correlated plasma and urinary levels of caffeine in preterm infants treated with this drug for apnea of prematurity.
Methods: Infants (n=56) were given a loading dose of caffeine citrate (10 mg/kg, per os) and 24 h later a maintenance dose (2 mg/kg, per os, once a day)...
Keywords: Apnea of prematurity, caffeine, urinary excretion of caffeine, xantines
08/2006 | Journal of Perinatal Medicine, Walter de Gruyter